Immortalized Mouse Microglia (SIM-A9)

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Immortalized Cells

Tissue Type

Brain

Organism

Mouse (M. musculus)

Donor History

C57BL/6 mouse

Growth Properties

Adherent

,

round or polygonal

Growth Conditions
Immortalization Method

Spontaneous immortalization

Full Information

https://www.abmgood.com/immortalized-mouse-microglia-sim-a9.html

Katalogové číslo: T0247 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

Stimulation of microglia can be done by adding 2.5 ng/ml LPS, or 20 μM β-amyloid fibrils (Aβ1-42); upon LPS and IL-4 stimulation, these cells are capable of switching between the pro-inflammatory microglial phenotype, M1, which is associated with elevated iNOS and COX-2 followed by IкB and tyrosine kinase pathways and the regenerative-supportive phenotype, M2, which is identified by an increased in Arg-1 expression, respectivelyMicroglia cells are resident macrophages of the brain and spinal cord and they act as the first and the main form of active immune defense in the nervous system. In addition to expressing microglial specific markers CD68 and Iba1, the spontaneously Immortalized Mouse Microglia (SIM-A9) retains responsiveness to exogenous inflammatory stimulation (LPS and β-amyloid) and the ability to secrete cytokines and nitric oxide as well as phagocytose biological debris. Upon LPS and IL-4 stimulation, these cells are capable of switching between the pro-inflammatory microglial phenotype, M1, which is associated with elevated iNOS and COX-2 followed by IкB and tyrosine kinase pathways and the regenerative-supportive phenotype, M2, which is identified by an increased in Arg-1 expression, respectively. SIM-A9 exhibits key attributes of primary microglia and is useful in characterization of stimulus-triggered microglial migration, proliferation and phagocytosis

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.